Mack Gill
Directeur/Bestuurslid bij ALTIMMUNE, INC.
Vermogen: 19 951 $ op 30-04-2024
Profiel
John M.
Gill founded TetraLogic Pharmaceuticals Corp.
in 2001, where he worked as Director from 2013 to 2014.
Dr. Gill also currently works at Millennium Information Technologies Ltd., as Chief Executive Officer from 2013, Altimmune, Inc., as Independent Director from 2004, and Torstone Technology Ltd., as Chief Operating Officer.
Dr. Gill also formerly worked at PharmAthene, Inc., as President, Chief Executive Officer & Director from 2015 to 2017, 3-Dimensional Pharmaceuticals, Inc., as Chief Financial Officer, Director & Executive VP, PharmAthene, Inc., as Director in 2007, Theraclone Sciences, Inc., as Director, The Biotechnology Greenhouse Corp.
of Southeastern PA, as Director, Ben Franklin Technology Partners, as Director, FIS Capital Markets US LLC (Pennsylvania), as SVP-Corporate Development & Strategy, GSK Equity Investments Ltd., as President, US Department of Defense (District of Columbia), as Principal from 1971 to 1973, Smithkline & French Laboratories US, Inc., as Chief Operating Officer, SunGard Financial Systems, as President-Global Technology, Nova Pharmaceutical Corp., as Chief Operating Officer, GlaxoSmithKline LLC, as VP-Research & Development Operations, and Sungard Global Services France SA, as President in 2011.
Dr. Gill received his undergraduate degree in 1975 from Rutgers State University of New Jersey, graduate degree from Yale University, and undergraduate degree from the University of British Columbia.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ALTIMMUNE, INC.
0.00% | 22-03-2024 | 2 771 ( 0.00% ) | 19 951 $ | 30-04-2024 |
Actieve functies van Mack Gill
| Bedrijven | Functie | Begin |
|---|---|---|
| ALTIMMUNE, INC. | Directeur/Bestuurslid | 01-08-2004 |
Millennium Information Technologies Ltd.
 Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | Algemeen Directeur | 23-05-2013 |
Torstone Technology Ltd.
 Torstone Technology Ltd. Packaged SoftwareTechnology Services Torstone Technology Ltd. provides cross-asset securities and derivatives post-trade processing technology. The firm develops sell-side post-trade processing platform for multiple asset classes. Its services include hosting, consultancy, support and development & integration. The company was founded in January 12, 2011 and is headquartered in London, the United Kingdom. | Operationeel Directeur | - |
Eerdere bekende functies van Mack Gill
| Bedrijven | Functie | Einde |
|---|---|---|
PharmAthene, Inc.
 PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Algemeen Directeur | 01-05-2017 |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Oprichter | 29-01-2014 |
Sungard Global Services France SA
 Sungard Global Services France SA Information Technology ServicesTechnology Services Sungard Global Services France SA provides information technology services in the financial industry. The company is based in Paris, France. Sungard Global Services France was acquired by Softeam Cadextan SA, a subsidiary of the Government of France, from SunGard Corp. on July 27, 2012. | President | 01-03-2011 |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Directeur/Bestuurslid | 30-04-2008 |
PharmAthene, Inc. /Old/
 PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Directeur/Bestuurslid | 03-08-2007 |
Opleiding van Mack Gill
| Rutgers State University of New Jersey | Undergraduate Degree |
| University of British Columbia | Undergraduate Degree |
| Yale University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| ALTIMMUNE, INC. | Health Technology |
| Bedrijven in privébezit | 16 |
|---|---|
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
| US Department of Defense (District of Columbia) | Government |
PharmAthene, Inc.
PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
PharmAthene, Inc. /Old/
PharmAthene, Inc. /Old/ BiotechnologyHealth Technology PharmAthene, Inc. develops biotherapeutics to address biological pathogens and chemicals. It provides clinical and preclinical development for Bacillus anthracis a therapeutic anti-toxin for treatment of symptomatic patients infected with anthrax monoclonal. The company was founded in 2001 and is located in Annapolis, MD. | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
3-Dimensional Pharmaceuticals, Inc.
 3-Dimensional Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology 3-Dimensional Pharmaceuticals, Inc. was acquired by Johnson & Johnson. 3-Dimensional Pharmaceuticals, Inc. operates as a drug discovery and development company that has a pipeline of drug candidates in the areas of cancer and inflammation, and metabolic and cardiovascular diseases | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
FIS Data Systems, Inc.
 FIS Data Systems, Inc. Packaged SoftwareTechnology Services FIS Data Systems, Inc. engages in the provision of software and technology services. Its services include consulting, management, and professional. The company was founded by John M. Ryan on June 29, 1982 and is headquartered in Wayne, PA. | Technology Services |
SunGard Financial Systems
 SunGard Financial Systems Packaged SoftwareTechnology Services SunGard Financial Systems develops software for financial services institutions. The firm Offers software and IT services to institutions in the financial services industry. SunGard offers solutions for alternative investments, banks, brokerage& clearance, corporations, insurance, wealth & data management, and risk & compliance. The company is headquartered in New York, NY. | Technology Services |
Sungard Global Services France SA
Sungard Global Services France SA Information Technology ServicesTechnology Services Sungard Global Services France SA provides information technology services in the financial industry. The company is based in Paris, France. Sungard Global Services France was acquired by Softeam Cadextan SA, a subsidiary of the Government of France, from SunGard Corp. on July 27, 2012. | Technology Services |
Millennium Information Technologies Ltd.
Millennium Information Technologies Ltd. Packaged SoftwareTechnology Services Millennium Information Technologies Ltd. provides information technology solutions. It specializes in IT solutions for the financial and telecom industries. The firm also offers information technology infrastructure and consulting services. Its capital markets products include Millennium Exchange, Millennium SOR, Millennium MarketData, Millennium Surveillance, Millennium PostTrade and Millennium Gateway. The company was founded by Anthony Mahinda Thomas Weeresinghe in 1996 and is headquartered in Malabe, Sri Lanka. | Technology Services |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Commercial Services |
| Smithkline & French Laboratories US, Inc. | |
| Nova Pharmaceutical Corp. | |
Torstone Technology Ltd.
Torstone Technology Ltd. Packaged SoftwareTechnology Services Torstone Technology Ltd. provides cross-asset securities and derivatives post-trade processing technology. The firm develops sell-side post-trade processing platform for multiple asset classes. Its services include hosting, consultancy, support and development & integration. The company was founded in January 12, 2011 and is headquartered in London, the United Kingdom. | Technology Services |